文献速递关节外科

体重指数≥35患者全聚乙烯胫骨假体最低2年随访结果

Minimum 2-Year Outcomes of All-Polyethylene Tibial Components in Patients Who Have Body Mass Index of 35 or Greater.
PubMed 文献 · J Arthroplasty · 2023-04-04

回顾性分析163例肥胖患者(192膝)行骨水泥型全膝关节置换术并使用全聚乙烯胫骨假体,比较体重指数>35至39.9组与≥40组,中位随访3.8年与3.5年,两组患者报告结局无显著差异,以任何原因翻修为终点的生存率均为99%(P=1.00),多因素回归未发现年龄、性别、体重指数与并发症显著相关。

要点

  • 体重指数>35至39.9组与≥40组患者报告结局无显著差异。
  • 两组以任何原因翻修为终点的生存率均为99%(P=1.00)。
  • 多因素回归未发现年龄、性别、体重指数与并发症显著相关。

核心结论

  • 在中位3.7年随访时,使用全聚乙烯胫骨假体在2级和3级肥胖患者中提供了良好的结局和生存率。

研究设计与样本

  • 回顾性研究纳入163例肥胖患者(192膝)行初次骨水泥型全膝关节置换术并使用全聚乙烯胫骨假体。
  • 比较体重指数>35至39.9组(A组,96膝)与体重指数≥40组(B组,96膝)。
  • A组和B组中位随访分别为3.8年和3.5年(P=0.02)。
  • 采用多因素回归分析评估与并发症相关的独立危险因素。
  • 采用Kaplan-Meier生存曲线估计生存率,失败定义为需任何进一步股骨或胫骨翻修手术并移除假体,不论原因。

主要发现

  • 末次随访时两组患者报告结局无显著差异。
  • 以任何原因翻修为终点的生存率A组为99%,B组为99%(P=1.00)。
  • A组发生1例无菌性胫骨失败,B组发生1例感染性失败。
  • 多因素回归分析显示年龄(比值比[OR]=1.00;P=0.98;95%置信区间[CI]=0.93至1.08)与并发症率无显著关联。
  • 多因素回归分析显示性别(OR=1.38;P=0.70;95%CI=0.26至7.25)与并发症率无显著关联。

关键数值与推荐

  • 以任何原因翻修为终点的生存率A组为99%,B组为99%(P=1.00)。
  • 年龄与并发症关联的OR=1.00(P=0.98;95%CI=0.93至1.08)。
  • 性别与并发症关联的OR=1.38(P=0.70;95%CI=0.26至7.25)。
  • 体重指数与并发症关联的OR=1.00(P=0.95;95%CI=0.87至1.16)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies have reported negative results after total knee arthroplasty (TKA) in obese patients. This study aims to analyze the minimum 2-year outcomes in patients who have a body mass index (BMI) > 35 undergoing cemented TKA using an all-polyethylene tibial component (APTC) at a minimum of 2 years of follow-up. METHODS: We retrospectively studied 163 obese patients (192 TKAs) who underwent a primary cemented TKA using an APTC comparing the outcomes of 96 TKA patients who had a BMI > 35 to 39.9 (group A) with 96 patients who a TKA and a BMI ≥40 (group B). Median follow-up of groups A and B were 3.8 years and 3.5 years respectively (P = .02). Multiple regression analyses were performed to evaluate independent risk factors associated with complications. Kaplan-Meier survival curves were estimated, defining failure as the need for any further femoral or tibial revision surgery with implant removal, irrespective of the reason. RESULTS: There was no significant difference at the latest follow-up patient-reported outcomes between both groups. Survivorship, as defined by revision for any reason, was 99% for group A and 99% for group B (P = 1.00). There was 1 aseptic tibial failure in group A, and 1 septic failure in group B. Multiple regression analyses showed no significant associations between age (odds ratio [OR] = 1.00; P = .98; 95% confidence interval (CI) = 0.93 to 1.08), sex (OR = 1.38; P = .70; 95% CI = 0.26 to 7.25), BMI (OR = 1.00; P = .95; 95% CI = 0.87 to 1.16), and complication rate. CONCLUSION: At a median 3.7-year follow-up, the use of an APTC provided excellent outcomes and survivorship in patients who had Class 2 and Class 3 obesity. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Diaz Dilernia F, Blanchard T, Vasarhelyi E, et al. Minimum 2-Year Outcomes of All-Polyethylene Tibial Components in Patients Who Have Body Mass Index of 35 or Greater. J Arthroplasty. 2023. PMID: 37019318. doi:10.1016/j.arth.2023.03.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。